Two Sigma Advisers’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-107,400
| Closed | -$39.4K | – | 2422 |
|
|
2025
Q2 | $39.4K | Sell |
107,400
-85,700
| -44% | -$28.6K | ﹤0.01% | 2268 |
|
|
2025
Q1 | $50K | Buy |
193,100
+108,700
| +129% | +$62.1K | ﹤0.01% | 2322 |
|
|
2024
Q4 | $47.5K | Buy |
84,400
+27,300
| +48% | +$16.1K | ﹤0.01% | 2285 |
|
|
2024
Q3 | $34.3K | Buy |
+57,100
| New | +$84.7K | ﹤0.01% | 2235 |
|
|
2024
Q1 | – | Sell |
-102,700
| Closed | -$55.1K | – | 2501 |
|
|
2023
Q4 | $55.1K | Buy |
102,700
+25,900
| +34% | +$13.7K | ﹤0.01% | 2393 |
|
|
2023
Q3 | $50.9K | Buy |
+76,800
| New | +$77.7K | ﹤0.01% | 2274 |
|
